Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study

OBJECTIVE: To investigate the cost-effectiveness of a hypothetical cardioprotective agent used to reduce infarct size in patients undergoing percutaneous coronary intervention (PCI) after anterior ST-elevation myocardial infarction. METHODS: Design: A cost-utility analysis using a Markov model. Sett...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoef, Talitha I, Morris, Stephen, Mathur, Anthony, Singer, Mervyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654357/
https://www.ncbi.nlm.nih.gov/pubmed/26567251
http://dx.doi.org/10.1136/bmjopen-2015-008164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654357/
https://www.ncbi.nlm.nih.gov/pubmed/26567251
http://dx.doi.org/10.1136/bmjopen-2015-008164

Ejemplares similares